Related Experiment Video
Updated: Jun 9, 2026
10:54
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
Published on: November 21, 2025
[Evidence-based therapy of depression: S3 guidelines on unipolar depression]
M Härter1, C Klesse, I Bermejo
1Institut und Poliklinik für Medizinische Psychologie, Universitätsklinikum Hamburg-Eppendorf, Martinistrasse 52 (W 26), 20246, Hamburg, Deutschland. m.haerter@uke.uni-hamburg.de
Der Nervenarzt
|August 31, 2010
Summary
New German guidelines offer evidence-based recommendations for unipolar depression treatment. These guidelines align current best practices for diagnosis and therapy, including pharmacotherapy and psychotherapy, to improve patient outcomes.
Area of Science:
- Psychiatry and Neurology
- Clinical Psychology
Context:
- Unipolar depressive disorders represent a significant burden on healthcare systems.
- Existing treatments are effective, but diagnostic and therapeutic procedures require enhancement.
- Evidence-based treatment guidelines are crucial for optimal patient care.
Purpose:
- To present the state-of-the-art evidence and clinical consensus for treating unipolar depression.
- To introduce the new S3 and National Health Care guidelines for unipolar depression.
- To provide differentiated recommendations for pharmacotherapy, separate from or in addition to psychotherapy.
Summary:
- The German Society of Psychiatry, Psychotherapy and Neurology (DGPPN) coordinated the development of comprehensive S3 and National Health Care guidelines.
- These guidelines were approved by 29 scientific and professional associations.
- They offer clear recommendations for the pharmacotherapy of depression, considering its use alongside or independently of psychotherapy.
Impact:
- Improved diagnostic and therapeutic procedures for unipolar depression.
- Standardized, evidence-based treatment protocols across healthcare settings.
- Enhanced clinical decision-making for healthcare professionals treating depression.
Related Concept Videos
01:30Electroconvulsive Therapy
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:18Depression: Overview
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
01:25Cognitive Therapy
Cognitive therapy, pioneered by Aaron T. Beck in the 1960s, is a structured approach to addressing psychological distress by focusing on the influence of thoughts on emotions and behaviors. All cognitive therapies involve the basic assumption that human beings have control over their feelings, and that how individuals feel about something depends on how they think about it. Unlike psychoanalytic methods that delve into unconscious processes or humanistic approaches emphasizing...
01:27Depressive Disorders: Etiology
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...